|Medical news of Remedium.ru portal is the most update information on pharmaceutical and medical equipment market|
Home / News
Pfizer to Start from Scratch
The plant’s construction is the most probable choice because of high prices for existing production facilities and the need to invest in their upgrade and rebuilding, a Pfizer representative specified, promising to give detailed information in early August.
If the Americans finally decide in favor of construction project, Pfizer will be the second global pharmaceutical blockbuster building a plant in Russia. The pioneer is French Servier that completed construction of ?40-million plant in the Moscow region in summer. “But Pfizer’s appearance is the event of much greater extent, comparable to GlaxoSmithKline’s full-scale arrival in Russia,” said David Melik-Gusseinov, head of the market survey department at Pharmexpert.
According to market players, GlaxoSmithKline is currently negotiating the buy-out of Veropharm from 36.6 Pharmacy Chain and investors’ consortium led by Standard Bank.